Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 978.2 million compared to CNY 971.04 million a year ago. Revenue was CNY 980.83 million compared to CNY 974.29 million a year ago.

Net income was CNY 110.43 million compared to CNY 101.16 million a year ago. Basic earnings per share from continuing operations was CNY 1.15 compared to CNY 1.18 a year ago. Diluted earnings per share from continuing operations was CNY 1.13 compared to CNY 1.17 a year ago.